openPR Logo
Press release

Projected Growth and Ascending Trends in the Global Osteoporosis Drugs Market: Detailed CAGR Analysis and Major Key Players

01-31-2025 01:24 PM CET | IT, New Media & Software

Press release from: The Business Research Company

Projected Growth and Ascending Trends in the Global Osteoporosis Drugs Market

Projected Growth and Ascending Trends in the Global Osteoporosis Drugs Market

Expected to Ascend from $12.33 Billion in 2024 to $14.48 Billion in 2029 at a Steady CAGR: Analysis of Drivers and Trends in the Osteoporosis Drugs Market

What Is The Projected Market Size Of The Global Osteoporosis Drugs Market And Its Growth Rate?
• The osteoporosis drugs market size will grow from $12.33 billion in 2024 to $12.8 billion in 2025 at a compound annual growth rate (CAGR) of3.8%.
• The market is expected to rise to $14.48 billion in 2029 at a compound annual growth rate (CAGR) of 3.1%.

What Is Driving The Growth In The Osteoporosis Drugs Market?
The prevalence of osteoporosis has seen a significant surge, leading to an increase in demand for osteoporosis drugs. Osteoporosis is a disease affecting bone quality and density, particularly prevalent among individuals with a low calcium intake. The use of osteoporosis drugs facilitates an increase in bone mineral density, thereby assisting in the prevention of fractures. For instance, the Australian Institute of Health and Welfare reported that in 2022, osteoporosis accounted for 2,659 deaths, or 1.4% of all fatalities. Therefore, such increasing prevalence of osteoporosis is driving the growth of the osteoporosis drugs market.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9102&type=smp

Who Are the Key Players Driving Osteoporosis Drugs Market Growth?
• Pfizer Inc.
• F. Hoffmann La Roche Ltd.
• Merck & Co Inc.
• Novartis AG
• Bristol Myers Squibb Company
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Amgen Inc.
• Novo Nordisk A/S
• Asahi Kasei Pharma Corporation
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd
• Mylan N.V.
• Daiichi Sankyo Company Limited
• Sun Pharmaceutical Industries Ltd.
• Ipsen, Kyowa Kirin Co Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Recordati S.p.A.
• Cadila Healthcare Ltd.
• Lupin Limited
• Torrent Pharmaceuticals Ltd.
• Sunovion Pharmaceuticals Inc.
• Theramex
• Radius Health Inc.
• Strides Pharma Science Limited
• Apotex Inc.

What Are The Key Trends In The Osteoporosis Drugs Market?
• Personalized medicine approaches
• Exploration of combination therapies
• Focus on fracture prevention strategies
• R&D investment in novel drug targets
• Collaborations for drug development

What Are The Segments Of The Global Osteoporosis Drugs Market?
• By Type: Bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), RANK Ligand Inhibitors
• By Administration: Oral, Injectable
• By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Sales
• By Application: Primary Osteoporosis, Secondary Osteoporosis

Which Region Leads The Osteoporosis Drugs Market?
North America was the largest region in the osteoporosis market in 2024. The regions covered in this report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/osteoporosis-drugs-global-market-report

What Is Covered In The Osteoporosis Drugs Market Global Market Report?
- Market Size Analysis: Analyze the Osteoporosis Drugs Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Osteoporosis Drugs Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Osteoporosis Drugs Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Osteoporosis Drugs Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=9102&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: mailto:info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Learn More About The Business Research Company

The Business Research Company ( https://www.thebusinessresearchcompany.com ) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Projected Growth and Ascending Trends in the Global Osteoporosis Drugs Market: Detailed CAGR Analysis and Major Key Players here

News-ID: 3844258 • Views:

More Releases from The Business Research Company

Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Foam Tape Industry to Achieve $14.62 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. How Will the Foam Tape Market Grow by 2025 in Terms of Size and Growth? In recent times, there has been significant growth in the market size for foam tape. It is projected to escalate from $10.02 billion in 2024 to $10.77 billion in 2025, demonstrating a compound annual growth rate (CAGR)
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 Billion in 2029
Continuous Positive Airway Pressure (CPAP) Mask Market Expansion Outlook: $3.85 …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Projected CAGR for the Continuous Positive Airway Pressure (CPAP) Mask Market from 2024 to 2025? In recent times, the market size of the continuous positive airway pressure (cpap) mask has seen robust growth. The market is projected to rise from $2.83 billion in 2024 to $3 billion in 2025,
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis Report
Alkyd Coating Market to Record 7.5% CAGR Growth Through 2029 | Global Analysis R …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Alkyd Coating Market Outlook: How is the Market Expected to Grow by 2025? The market size of alkyd coatings has experienced significant growth in the past few years. The market is projected to expand from $25.13 billion in 2024 to $26.74 billion in 2025, exhibiting a compound annual growth rate
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Water Free Skincare Market Analysis: $22.5 Billion by 2029 With a CAGR of 7%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. Water Free Skincare Market Value Projection: How Much Will the Market Size by 2025? The market size of waterless skincare has experienced a robust increase in recent years. The expected growth is from $15.96 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%.

All 5 Releases


More Releases for Osteoporosis

Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period? The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate? The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss. View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss. The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample Although osteoporosis cannot be treated, it can be slowed down or
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related